Skip to main content
OpenTrials
Completed

NCT Number: NCT01889771

A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline

The study is to understand whether distribution of two different supplies of nicotine patches through a telephone quitline has an effect on quit rates. The two different supplies are four vs. eight (in two separate four-week mailings) weeks of nicotine patches. The hypothesis is that eight weeks will be slightly more efficacious but four weeks will be more cost-effective.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All callers to the Colorado QuitLine who report currently smoking 16-20 cigarettes
  • who enroll in QuitLine services
  • who do not require physician approval to obtain nicotine replacement therapy
  • who are willing to receive the nicotine patch

Exclusion criteria

  • Contraindications to receiving the nicotine patch through the QuitLine without physician approval include: history of hearth disease (heart attack, chest pain, or coronary artery disease), high blood pressure, pregnancy, skin conditions such as difficult to manage psoriasis or eczema, or history of a local reaction to the nicotine patch
  • those who do not complete the call in English

Treatment and study plan

Nicotine patch

Drug

nicoderm patches are distributed in two different supplies through a telephone quitline

Other names: Nicoderm Committed Quit patches

Primary outcomes

  1. 7-day smoking abstinence

    Time frame: 7 days

  2. 6-month smoking abstinence

    Time frame: 6 months

  3. cost-effectiveness

    Time frame: 6 months

    cost per quit of each study arm will be calculated based on the total costs of the intervention from actual utilization data (nicotine patch costs + counseling call costs) and quit rates

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Jun 28, 2013
Registry last updated
Feb 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.